| M | SD | N | F | dfM | dfR | p | ω2 |
---|---|---|---|---|---|---|---|---|
Primary outcome | Â | Â | Â | Â | Â | Â | Â | Â |
CDRS-R | Â | Â | Â | Â | Â | Â | Â | Â |
Pre-test | 53.80 | 12.24 | 15 | Â | Â | Â | Â | Â |
Post-test | 45.93 | 12.11 | 15 | Â | Â | Â | Â | Â |
Follow-up | 40.75 | 14.39 | 12 | 11.76 | 1 | 11.92 | .005** | .11 |
Secondary outcomes | Â | Â | Â | Â | Â | Â | Â | Â |
BDI-II | Â | Â | Â | Â | Â | Â | Â | Â |
Pre-test | 26.64 | 14.00 | 14 | Â | Â | Â | Â | Â |
Post-test | 20.67 | 13.45 | 15 | Â | Â | Â | Â | Â |
Follow-up | 14.50 | 9.98 | 12 | 11.19 | 1 | 31.97 | .002** | .01 |
IQLC | Â | Â | Â | Â | Â | Â | Â | Â |
Pre-test | 20.60 | 3.85 | 15 | Â | Â | Â | Â | Â |
Post-test | 19.13 | 4.03 | 15 | Â | Â | Â | Â | Â |
Follow-up | 18.42 | 4.19 | 12 | 5.27 | 1 | 30.57 | .03* | .03 |
HoNOSCA | Â | Â | Â | Â | Â | Â | Â | Â |
Pre-test | 13.60 | 5.88 | 15 | Â | Â | Â | Â | Â |
Post-test | 13.14 | 6.02 | 14 | Â | Â | Â | Â | Â |
Follow-up | 9.25 | 5.14 | 12 | 4.54 | 1 | 36.92 | .04* | .04 |
FBB-DES | Â | Â | Â | Â | Â | Â | Â | Â |
Pre-test | 21.93 | 14.18 | 15 | Â | Â | Â | Â | Â |
Post-test | 23.31 | 12.30 | 13 | Â | Â | Â | Â | Â |
Follow-up | 17.11 | 7.90 | 9 | .94 | 1 | 27.02 | .34 | .01 |
CGI-S | Â | Â | Â | Â | Â | Â | Â | Â |
Pre-test | 4.00 | 1.07 | 15 | Â | Â | Â | Â | Â |
Post-test | 4.00 | 1.00 | 15 | Â | Â | Â | Â | Â |
Follow-up | 3.33 | 1.56 | 12 | 2.11 | 1 | 14.37 | .17 | .01 |